Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.55596260 |
2 | L-phenylalanine catabolic process (GO:0006559) | 5.55596260 |
3 | axon ensheathment in central nervous system (GO:0032291) | 5.52728355 |
4 | central nervous system myelination (GO:0022010) | 5.52728355 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.42076042 |
6 | L-phenylalanine metabolic process (GO:0006558) | 5.42076042 |
7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.42753963 |
8 | glutamate secretion (GO:0014047) | 4.20799913 |
9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.06725738 |
10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.02925437 |
11 | cellular potassium ion homeostasis (GO:0030007) | 4.00591465 |
12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.99876866 |
13 | glyoxylate metabolic process (GO:0046487) | 3.89395840 |
14 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.88593321 |
15 | mitochondrion transport along microtubule (GO:0047497) | 3.88593321 |
16 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.82464572 |
17 | myelin maintenance (GO:0043217) | 3.72743059 |
18 | sodium ion export (GO:0071436) | 3.72623995 |
19 | aromatic amino acid family catabolic process (GO:0009074) | 3.57018951 |
20 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.55510906 |
21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.51688713 |
22 | postsynaptic membrane organization (GO:0001941) | 3.43087869 |
23 | drug transmembrane transport (GO:0006855) | 3.40197925 |
24 | regulation of synaptic vesicle transport (GO:1902803) | 3.40133058 |
25 | dopamine receptor signaling pathway (GO:0007212) | 3.38093385 |
26 | neuromuscular process controlling balance (GO:0050885) | 3.36072649 |
27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.35689996 |
28 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.35509767 |
29 | cell migration in hindbrain (GO:0021535) | 3.33756390 |
30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.30239593 |
31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.30055553 |
32 | locomotory exploration behavior (GO:0035641) | 3.29137368 |
33 | neurotransmitter secretion (GO:0007269) | 3.27518781 |
34 | myelination (GO:0042552) | 3.24499901 |
35 | axon ensheathment (GO:0008366) | 3.23389307 |
36 | ensheathment of neurons (GO:0007272) | 3.23389307 |
37 | aspartate family amino acid catabolic process (GO:0009068) | 3.21710989 |
38 | positive regulation of synapse maturation (GO:0090129) | 3.19319369 |
39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.14523918 |
40 | vocalization behavior (GO:0071625) | 3.13428555 |
41 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.13382057 |
42 | dendritic spine morphogenesis (GO:0060997) | 3.12511099 |
43 | regulation of ARF protein signal transduction (GO:0032012) | 3.12167179 |
44 | response to parathyroid hormone (GO:0071107) | 3.09826304 |
45 | cell-cell junction maintenance (GO:0045217) | 3.05852625 |
46 | L-amino acid import (GO:0043092) | 3.03688458 |
47 | regulation of female receptivity (GO:0045924) | 3.02583867 |
48 | female mating behavior (GO:0060180) | 2.99978819 |
49 | exocrine pancreas development (GO:0031017) | 2.98332029 |
50 | fatty acid elongation (GO:0030497) | 2.98240996 |
51 | synaptic vesicle maturation (GO:0016188) | 2.93997418 |
52 | potassium ion homeostasis (GO:0055075) | 2.93779147 |
53 | response to mercury ion (GO:0046689) | 2.91718379 |
54 | layer formation in cerebral cortex (GO:0021819) | 2.91185594 |
55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.88535004 |
56 | cellular modified amino acid catabolic process (GO:0042219) | 2.86385172 |
57 | dicarboxylic acid catabolic process (GO:0043649) | 2.85792948 |
58 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85188292 |
59 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.83159575 |
60 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.82343345 |
61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.80894811 |
62 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.80723007 |
63 | axonal fasciculation (GO:0007413) | 2.79378964 |
64 | short-chain fatty acid metabolic process (GO:0046459) | 2.78598077 |
65 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.77013055 |
66 | very long-chain fatty acid metabolic process (GO:0000038) | 2.76266219 |
67 | cysteine metabolic process (GO:0006534) | 2.75414508 |
68 | amino acid import (GO:0043090) | 2.73461250 |
69 | regulation of autophagic vacuole assembly (GO:2000785) | 2.73149855 |
70 | endocrine pancreas development (GO:0031018) | 2.72436742 |
71 | tricarboxylic acid metabolic process (GO:0072350) | 2.71350108 |
72 | metanephric nephron epithelium development (GO:0072243) | 2.71169583 |
73 | apical protein localization (GO:0045176) | 2.70599252 |
74 | glutamate metabolic process (GO:0006536) | 2.70228586 |
75 | activation of protein kinase A activity (GO:0034199) | 2.68791740 |
76 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.68610690 |
77 | synaptic transmission, glutamatergic (GO:0035249) | 2.68556961 |
78 | lysine catabolic process (GO:0006554) | 2.68342407 |
79 | lysine metabolic process (GO:0006553) | 2.68342407 |
80 | exploration behavior (GO:0035640) | 2.66127871 |
81 | positive regulation of dendritic spine development (GO:0060999) | 2.65951208 |
82 | negative regulation of cell size (GO:0045792) | 2.64914239 |
83 | negative regulation of catenin import into nucleus (GO:0035414) | 2.64643169 |
84 | positive regulation of neurotransmitter transport (GO:0051590) | 2.63252743 |
85 | regulation of synapse structural plasticity (GO:0051823) | 2.62963164 |
86 | neuron recognition (GO:0008038) | 2.62473406 |
87 | bile acid biosynthetic process (GO:0006699) | 2.61810173 |
88 | L-serine metabolic process (GO:0006563) | 2.59984793 |
89 | metanephric nephron tubule development (GO:0072234) | 2.59866912 |
90 | metanephric tubule development (GO:0072170) | 2.59866912 |
91 | neuron projection regeneration (GO:0031102) | 2.59108605 |
92 | regulation of cholesterol homeostasis (GO:2000188) | 2.58873455 |
93 | coenzyme catabolic process (GO:0009109) | 2.58743163 |
94 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.58588336 |
95 | asymmetric protein localization (GO:0008105) | 2.58552783 |
96 | regulation of synaptic plasticity (GO:0048167) | 2.58037165 |
97 | camera-type eye morphogenesis (GO:0048593) | 2.57043260 |
98 | cell communication by electrical coupling (GO:0010644) | 2.56863132 |
99 | serine family amino acid biosynthetic process (GO:0009070) | 2.56241572 |
100 | creatine metabolic process (GO:0006600) | 2.56065589 |
101 | synaptic vesicle endocytosis (GO:0048488) | 2.55882319 |
102 | sulfur amino acid catabolic process (GO:0000098) | 2.54196455 |
103 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.53845685 |
104 | phosphate ion transport (GO:0006817) | 2.53836345 |
105 | regulation of neurotransmitter levels (GO:0001505) | 2.53128000 |
106 | axon extension (GO:0048675) | 2.51559916 |
107 | cellular amino acid catabolic process (GO:0009063) | 2.50914981 |
108 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.50128277 |
109 | neurotransmitter transport (GO:0006836) | 2.49994402 |
110 | alpha-amino acid catabolic process (GO:1901606) | 2.49047049 |
111 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.48582886 |
112 | neuronal action potential propagation (GO:0019227) | 2.48096049 |
113 | response to pheromone (GO:0019236) | 2.47919257 |
114 | barbed-end actin filament capping (GO:0051016) | 2.46882214 |
115 | positive regulation of axon extension (GO:0045773) | 2.46016719 |
116 | metanephric epithelium development (GO:0072207) | 2.45930402 |
117 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.45187374 |
118 | Golgi transport vesicle coating (GO:0048200) | 2.41718873 |
119 | COPI coating of Golgi vesicle (GO:0048205) | 2.41718873 |
120 | transmission of nerve impulse (GO:0019226) | 2.41499693 |
121 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.41381987 |
122 | regulation of neurotransmitter secretion (GO:0046928) | 2.41169058 |
123 | response to methylmercury (GO:0051597) | 2.40986618 |
124 | neuromuscular synaptic transmission (GO:0007274) | 2.40600779 |
125 | aromatic amino acid family metabolic process (GO:0009072) | 2.40403927 |
126 | protein import into peroxisome matrix (GO:0016558) | 2.40263544 |
127 | drug transport (GO:0015893) | 2.40005981 |
128 | viral transcription (GO:0019083) | 2.38458186 |
129 | dendritic spine organization (GO:0097061) | 2.38367628 |
130 | positive regulation of dendrite development (GO:1900006) | 2.38070416 |
131 | cell volume homeostasis (GO:0006884) | 2.38044366 |
132 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.37233130 |
133 | hyperosmotic salinity response (GO:0042538) | 2.36872726 |
134 | cerebellar granule cell differentiation (GO:0021707) | 2.36625986 |
135 | protein retention in ER lumen (GO:0006621) | 2.35676516 |
136 | adenosine receptor signaling pathway (GO:0001973) | 2.34741018 |
137 | Peyers patch development (GO:0048541) | 2.34678581 |
138 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.34678581 |
139 | neuron cell-cell adhesion (GO:0007158) | 2.34180730 |
140 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.34046734 |
141 | glandular epithelial cell differentiation (GO:0002067) | 2.31649685 |
142 | neuromuscular process controlling posture (GO:0050884) | 2.31431951 |
143 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.31228402 |
144 | cell differentiation in hindbrain (GO:0021533) | 2.30931102 |
145 | negative regulation of axonogenesis (GO:0050771) | 2.30302758 |
146 | L-serine transport (GO:0015825) | 2.30156384 |
147 | coenzyme A metabolic process (GO:0015936) | 2.29845883 |
148 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.29647353 |
149 | serine family amino acid metabolic process (GO:0009069) | 2.28584897 |
150 | tyrosine metabolic process (GO:0006570) | 2.26585126 |
151 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.25765117 |
152 | polarized epithelial cell differentiation (GO:0030859) | 2.24548492 |
153 | C4-dicarboxylate transport (GO:0015740) | 2.23007063 |
154 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.22194559 |
155 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.22194559 |
156 | cellular ketone body metabolic process (GO:0046950) | 2.21804934 |
157 | primitive streak formation (GO:0090009) | 2.21414015 |
158 | positive regulation of insulin secretion (GO:0032024) | 2.20392711 |
159 | bile acid metabolic process (GO:0008206) | 2.20136928 |
160 | branched-chain amino acid metabolic process (GO:0009081) | 2.19673690 |
161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.19150920 |
162 | neuronal ion channel clustering (GO:0045161) | 2.18317287 |
163 | potassium ion import (GO:0010107) | 2.16304687 |
164 | cranial nerve development (GO:0021545) | 2.16245818 |
165 | branched-chain amino acid catabolic process (GO:0009083) | 2.15689912 |
166 | valine metabolic process (GO:0006573) | 2.15021796 |
167 | protein-DNA complex disassembly (GO:0032986) | 2.14323203 |
168 | nucleosome disassembly (GO:0006337) | 2.14323203 |
169 | establishment of mitochondrion localization (GO:0051654) | 2.14227536 |
170 | lens fiber cell development (GO:0070307) | 2.13908367 |
171 | peroxisome fission (GO:0016559) | 2.13124690 |
172 | synaptic vesicle exocytosis (GO:0016079) | 2.13106106 |
173 | kynurenine metabolic process (GO:0070189) | 2.12983099 |
174 | protein maturation by protein folding (GO:0022417) | 2.12829074 |
175 | nephron tubule formation (GO:0072079) | 2.12794520 |
176 | negative regulation of fibrinolysis (GO:0051918) | 2.12773240 |
177 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.12424009 |
178 | 4-hydroxyproline metabolic process (GO:0019471) | 2.08111435 |
179 | glycine metabolic process (GO:0006544) | 2.07690654 |
180 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.07057136 |
181 | cerebellar Purkinje cell layer development (GO:0021680) | 2.07040204 |
182 | organic acid catabolic process (GO:0016054) | 2.06871682 |
183 | carboxylic acid catabolic process (GO:0046395) | 2.06871682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.01012638 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.44305350 |
3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.02662445 |
4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.55195363 |
5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.43298824 |
6 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.32080055 |
7 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.11139943 |
8 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09336517 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05992356 |
10 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.04800456 |
11 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03552823 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02290887 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02290887 |
14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00804375 |
15 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.95298990 |
16 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.94492876 |
17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.92505062 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91093505 |
19 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.90940244 |
20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89151050 |
21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.88520779 |
22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87791582 |
23 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87675257 |
24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.86068828 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.85656142 |
26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79541164 |
27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.77219890 |
28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77016121 |
29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76816922 |
30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76618978 |
31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76602572 |
32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75181174 |
33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.75058575 |
34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75050121 |
35 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70819943 |
36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66287432 |
37 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.66148495 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65803843 |
39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65492159 |
40 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.60307059 |
41 | * MYC_22102868_ChIP-Seq_BL_Human | 1.59527019 |
42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59477447 |
43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.59070810 |
44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56868083 |
45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56186763 |
46 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.55614261 |
47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.53818086 |
48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.51447482 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50085004 |
50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46480957 |
51 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45822570 |
52 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.45389588 |
53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.43309792 |
54 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.42284778 |
55 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.36735180 |
56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35325663 |
57 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.35256427 |
58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34996132 |
59 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34861604 |
60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34318766 |
61 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.33667311 |
62 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32167907 |
63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32053491 |
64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31913860 |
65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30872994 |
66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29390276 |
67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28595685 |
68 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27881157 |
69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25116036 |
70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24898905 |
71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24524496 |
72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24089961 |
73 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23418668 |
74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23191351 |
75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23008614 |
76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22152510 |
77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18199811 |
78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16070060 |
79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15352032 |
80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14861572 |
81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14769510 |
82 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14548464 |
83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13891649 |
84 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13095551 |
85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12523842 |
86 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12489022 |
87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12030358 |
88 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11282067 |
89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10445392 |
90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09697193 |
91 | P68_20966046_ChIP-Seq_HELA_Human | 1.08796918 |
92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07742402 |
93 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06741053 |
94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06436798 |
95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06283408 |
96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05459350 |
97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05331395 |
98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04787970 |
99 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04552899 |
100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04070123 |
101 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04033608 |
102 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 1.03925922 |
103 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.02153157 |
104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02119290 |
105 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01583059 |
106 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99130121 |
107 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97930308 |
108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97757151 |
109 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97699963 |
110 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97648279 |
111 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97498218 |
112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96654848 |
113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95543330 |
114 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94912501 |
115 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.94775324 |
116 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93890014 |
117 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.93872672 |
118 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.92627588 |
119 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91822587 |
120 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.90586101 |
121 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88931895 |
122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88841963 |
123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88833738 |
124 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.87133883 |
125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84199306 |
126 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83655159 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.47866224 |
2 | MP0009278_abnormal_bone_marrow | 3.05992582 |
3 | MP0004043_abnormal_pH_regulation | 3.01690820 |
4 | MP0005365_abnormal_bile_salt | 2.97024263 |
5 | MP0003123_paternal_imprinting | 2.90669505 |
6 | MP0003787_abnormal_imprinting | 2.79734670 |
7 | MP0005360_urolithiasis | 2.62744834 |
8 | MP0002822_catalepsy | 2.60807991 |
9 | MP0009780_abnormal_chondrocyte_physiolo | 2.56896344 |
10 | MP0005058_abnormal_lysosome_morphology | 2.48402183 |
11 | MP0004885_abnormal_endolymph | 2.36091853 |
12 | MP0003283_abnormal_digestive_organ | 2.30568563 |
13 | MP0005085_abnormal_gallbladder_physiolo | 2.24311192 |
14 | MP0002653_abnormal_ependyma_morphology | 2.21494898 |
15 | MP0009379_abnormal_foot_pigmentation | 2.21035068 |
16 | MP0005220_abnormal_exocrine_pancreas | 2.20495269 |
17 | MP0004270_analgesia | 2.07508060 |
18 | MP0001968_abnormal_touch/_nociception | 2.04731920 |
19 | MP0003195_calcinosis | 1.99694250 |
20 | MP0004859_abnormal_synaptic_plasticity | 1.99310003 |
21 | MP0008875_abnormal_xenobiotic_pharmacok | 1.99285267 |
22 | MP0003172_abnormal_lysosome_physiology | 1.96406212 |
23 | MP0000920_abnormal_myelination | 1.87474815 |
24 | MP0006072_abnormal_retinal_apoptosis | 1.82974200 |
25 | MP0003868_abnormal_feces_composition | 1.82348463 |
26 | MP0003880_abnormal_central_pattern | 1.81464324 |
27 | MP0004145_abnormal_muscle_electrophysio | 1.81211491 |
28 | MP0005332_abnormal_amino_acid | 1.78860657 |
29 | MP0002272_abnormal_nervous_system | 1.71447237 |
30 | MP0003635_abnormal_synaptic_transmissio | 1.70492240 |
31 | MP0001944_abnormal_pancreas_morphology | 1.69922049 |
32 | MP0002909_abnormal_adrenal_gland | 1.60978484 |
33 | MP0000955_abnormal_spinal_cord | 1.60456465 |
34 | MP0009384_cardiac_valve_regurgitation | 1.58621741 |
35 | MP0003329_amyloid_beta_deposits | 1.54984274 |
36 | MP0000678_abnormal_parathyroid_gland | 1.54099944 |
37 | MP0005083_abnormal_biliary_tract | 1.53915940 |
38 | MP0003705_abnormal_hypodermis_morpholog | 1.53460027 |
39 | MP0003252_abnormal_bile_duct | 1.50557663 |
40 | MP0002064_seizures | 1.50079078 |
41 | MP0002733_abnormal_thermal_nociception | 1.50065622 |
42 | MP0009046_muscle_twitch | 1.49820704 |
43 | MP0000604_amyloidosis | 1.48571770 |
44 | MP0001502_abnormal_circadian_rhythm | 1.44078707 |
45 | MP0001440_abnormal_grooming_behavior | 1.41730710 |
46 | MP0003122_maternal_imprinting | 1.41174115 |
47 | MP0002735_abnormal_chemical_nociception | 1.40793799 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.40741291 |
49 | MP0001545_abnormal_hematopoietic_system | 1.40741291 |
50 | MP0004133_heterotaxia | 1.39888859 |
51 | MP0008569_lethality_at_weaning | 1.38123683 |
52 | MP0001666_abnormal_nutrient_absorption | 1.37982251 |
53 | MP0001970_abnormal_pain_threshold | 1.35797223 |
54 | MP0004142_abnormal_muscle_tone | 1.35782059 |
55 | MP0000534_abnormal_ureter_morphology | 1.30802099 |
56 | MP0000747_muscle_weakness | 1.27098173 |
57 | MP0000462_abnormal_digestive_system | 1.26784598 |
58 | MP0002736_abnormal_nociception_after | 1.25962476 |
59 | MP0003191_abnormal_cellular_cholesterol | 1.25258699 |
60 | MP0008961_abnormal_basal_metabolism | 1.24684955 |
61 | MP0005410_abnormal_fertilization | 1.23448937 |
62 | MP0005423_abnormal_somatic_nervous | 1.22989023 |
63 | MP0003075_altered_response_to | 1.22886467 |
64 | MP0004858_abnormal_nervous_system | 1.22225497 |
65 | MP0004233_abnormal_muscle_weight | 1.21430320 |
66 | MP0003806_abnormal_nucleotide_metabolis | 1.20765877 |
67 | MP0000631_abnormal_neuroendocrine_gland | 1.20727830 |
68 | MP0000751_myopathy | 1.20185712 |
69 | MP0003942_abnormal_urinary_system | 1.19335156 |
70 | MP0002184_abnormal_innervation | 1.18442543 |
71 | MP0010030_abnormal_orbit_morphology | 1.17883000 |
72 | MP0002229_neurodegeneration | 1.17140298 |
73 | MP0002089_abnormal_postnatal_growth/wei | 1.15099598 |
74 | MP0005551_abnormal_eye_electrophysiolog | 1.14574618 |
75 | MP0000778_abnormal_nervous_system | 1.14555477 |
76 | MP0009745_abnormal_behavioral_response | 1.13086839 |
77 | MP0002234_abnormal_pharynx_morphology | 1.12934408 |
78 | MP0001486_abnormal_startle_reflex | 1.12322246 |
79 | MP0004811_abnormal_neuron_physiology | 1.10280561 |
80 | MP0002693_abnormal_pancreas_physiology | 1.09890651 |
81 | MP0005646_abnormal_pituitary_gland | 1.08968260 |
82 | MP0000639_abnormal_adrenal_gland | 1.08816379 |
83 | MP0002882_abnormal_neuron_morphology | 1.08534578 |
84 | MP0006276_abnormal_autonomic_nervous | 1.04213827 |
85 | MP0003690_abnormal_glial_cell | 1.04081187 |
86 | MP0009840_abnormal_foam_cell | 1.03927055 |
87 | MP0002118_abnormal_lipid_homeostasis | 1.02573176 |
88 | MP0003119_abnormal_digestive_system | 1.02146849 |
89 | MP0001765_abnormal_ion_homeostasis | 1.02133866 |
90 | MP0001963_abnormal_hearing_physiology | 1.01547267 |
91 | MP0001348_abnormal_lacrimal_gland | 1.00662098 |
92 | MP0002557_abnormal_social/conspecific_i | 1.00540312 |
93 | MP0003121_genomic_imprinting | 1.00378044 |
94 | MP0005645_abnormal_hypothalamus_physiol | 0.99534547 |
95 | MP0002078_abnormal_glucose_homeostasis | 0.99057834 |
96 | MP0009643_abnormal_urine_homeostasis | 0.98556463 |
97 | MP0003183_abnormal_peptide_metabolism | 0.97400841 |
98 | MP0002066_abnormal_motor_capabilities/c | 0.97157007 |
99 | MP0002572_abnormal_emotion/affect_behav | 0.96705375 |
100 | MP0001905_abnormal_dopamine_level | 0.96679711 |
101 | MP0001664_abnormal_digestion | 0.96572962 |
102 | MP0006036_abnormal_mitochondrial_physio | 0.96199441 |
103 | MP0002152_abnormal_brain_morphology | 0.95781047 |
104 | MP0009672_abnormal_birth_weight | 0.95592372 |
105 | MP0000003_abnormal_adipose_tissue | 0.94759635 |
106 | MP0003279_aneurysm | 0.94630177 |
107 | MP0000013_abnormal_adipose_tissue | 0.94567029 |
108 | MP0002063_abnormal_learning/memory/cond | 0.93995567 |
109 | MP0002734_abnormal_mechanical_nocicepti | 0.92300972 |
110 | MP0002067_abnormal_sensory_capabilities | 0.92240230 |
111 | MP0002249_abnormal_larynx_morphology | 0.91976478 |
112 | MP0005409_darkened_coat_color | 0.91871014 |
113 | MP0000681_abnormal_thyroid_gland | 0.91830117 |
114 | MP0003634_abnormal_glial_cell | 0.91506852 |
115 | MP0010329_abnormal_lipoprotein_level | 0.90565817 |
116 | MP0005253_abnormal_eye_physiology | 0.90408003 |
117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88043425 |
118 | MP0010368_abnormal_lymphatic_system | 0.87892132 |
119 | MP0001485_abnormal_pinna_reflex | 0.87654572 |
120 | MP0003632_abnormal_nervous_system | 0.87476311 |
121 | MP0000049_abnormal_middle_ear | 0.87014943 |
122 | MP0006292_abnormal_olfactory_placode | 0.85571551 |
123 | MP0004510_myositis | 0.85235699 |
124 | MP0002638_abnormal_pupillary_reflex | 0.83442301 |
125 | MP0002752_abnormal_somatic_nervous | 0.81840604 |
126 | MP0003633_abnormal_nervous_system | 0.80968005 |
127 | MP0003959_abnormal_lean_body | 0.80352542 |
128 | MP0002938_white_spotting | 0.78751587 |
129 | MP0003861_abnormal_nervous_system | 0.78105264 |
130 | MP0003631_nervous_system_phenotype | 0.76780510 |
131 | MP0003879_abnormal_hair_cell | 0.76316447 |
132 | MP0002928_abnormal_bile_duct | 0.74868494 |
133 | MP0004134_abnormal_chest_morphology | 0.74657497 |
134 | MP0000749_muscle_degeneration | 0.73453277 |
135 | MP0008874_decreased_physiological_sensi | 0.72681217 |
136 | MP0000759_abnormal_skeletal_muscle | 0.71085712 |
137 | MP0005535_abnormal_body_temperature | 0.70735967 |
138 | MP0001984_abnormal_olfaction | 0.70236402 |
139 | MP0000026_abnormal_inner_ear | 0.68027477 |
140 | MP0004924_abnormal_behavior | 0.67211853 |
141 | MP0005386_behavior/neurological_phenoty | 0.67211853 |
142 | MP0010386_abnormal_urinary_bladder | 0.64289650 |
143 | MP0002254_reproductive_system_inflammat | 0.63686686 |
144 | MP0001731_abnormal_postnatal_growth | 0.62994514 |
145 | MP0005499_abnormal_olfactory_system | 0.62799978 |
146 | MP0005394_taste/olfaction_phenotype | 0.62799978 |
147 | MP0005508_abnormal_skeleton_morphology | 0.62405592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.65867536 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.71079207 |
3 | Ketosis (HP:0001946) | 3.68852182 |
4 | Hypokalemic alkalosis (HP:0001949) | 3.50185076 |
5 | Obstructive sleep apnea (HP:0002870) | 3.43765742 |
6 | Ketoacidosis (HP:0001993) | 3.38767493 |
7 | Increased circulating renin level (HP:0000848) | 3.37138629 |
8 | Hypoglycemic coma (HP:0001325) | 3.32431545 |
9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.31711347 |
10 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.31711347 |
11 | Hypoglycemic seizures (HP:0002173) | 3.22801905 |
12 | Late onset (HP:0003584) | 3.09729474 |
13 | Ankle clonus (HP:0011448) | 3.07581300 |
14 | Intrahepatic cholestasis (HP:0001406) | 3.07185296 |
15 | Focal motor seizures (HP:0011153) | 3.06926292 |
16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.01738082 |
17 | Abnormality of binocular vision (HP:0011514) | 2.98444625 |
18 | Diplopia (HP:0000651) | 2.98444625 |
19 | Delayed CNS myelination (HP:0002188) | 2.94255513 |
20 | Deep venous thrombosis (HP:0002625) | 2.92781315 |
21 | J-shaped sella turcica (HP:0002680) | 2.91547584 |
22 | Distal lower limb muscle weakness (HP:0009053) | 2.84460901 |
23 | Hyperthyroidism (HP:0000836) | 2.82585887 |
24 | Focal seizures (HP:0007359) | 2.82442409 |
25 | Gout (HP:0001997) | 2.78062367 |
26 | Akinesia (HP:0002304) | 2.75275585 |
27 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.71882042 |
28 | Torticollis (HP:0000473) | 2.67104083 |
29 | Neurofibrillary tangles (HP:0002185) | 2.66154876 |
30 | Visual hallucinations (HP:0002367) | 2.65707454 |
31 | Fetal akinesia sequence (HP:0001989) | 2.65483541 |
32 | Dysostosis multiplex (HP:0000943) | 2.62696532 |
33 | Abnormal eating behavior (HP:0100738) | 2.57767535 |
34 | Increased cerebral lipofuscin (HP:0011813) | 2.51355611 |
35 | Hyperlipoproteinemia (HP:0010980) | 2.49293200 |
36 | Action tremor (HP:0002345) | 2.48870966 |
37 | Alkalosis (HP:0001948) | 2.42457181 |
38 | Annular pancreas (HP:0001734) | 2.42316403 |
39 | Symptomatic seizures (HP:0011145) | 2.38652944 |
40 | Mutism (HP:0002300) | 2.38529105 |
41 | Large for gestational age (HP:0001520) | 2.37630390 |
42 | Broad metatarsal (HP:0001783) | 2.36524378 |
43 | Metabolic alkalosis (HP:0200114) | 2.34681147 |
44 | Neuronal loss in central nervous system (HP:0002529) | 2.33486025 |
45 | Polyuria (HP:0000103) | 2.31684234 |
46 | Epileptic encephalopathy (HP:0200134) | 2.31354473 |
47 | Intention tremor (HP:0002080) | 2.28138741 |
48 | Polyphagia (HP:0002591) | 2.27828338 |
49 | Exercise-induced myalgia (HP:0003738) | 2.26595176 |
50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25700235 |
51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.24814031 |
52 | Craniofacial dystonia (HP:0012179) | 2.24505995 |
53 | Renovascular hypertension (HP:0100817) | 2.23086697 |
54 | Focal dystonia (HP:0004373) | 2.21068938 |
55 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20766607 |
56 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20766607 |
57 | Cerebral hypomyelination (HP:0006808) | 2.19333684 |
58 | Abnormal urine output (HP:0012590) | 2.19163327 |
59 | Diminished motivation (HP:0000745) | 2.18855808 |
60 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.18435313 |
61 | Megalencephaly (HP:0001355) | 2.18084959 |
62 | Sleep apnea (HP:0010535) | 2.17168940 |
63 | Type 1 muscle fiber predominance (HP:0003803) | 2.16911054 |
64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16141552 |
65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16141552 |
66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16141552 |
67 | Agitation (HP:0000713) | 2.15538766 |
68 | Split foot (HP:0001839) | 2.15195215 |
69 | Hyperglycinemia (HP:0002154) | 2.14840258 |
70 | Lower limb asymmetry (HP:0100559) | 2.14817963 |
71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.14581539 |
72 | Cerebral inclusion bodies (HP:0100314) | 2.14443749 |
73 | Round ear (HP:0100830) | 2.13935350 |
74 | Mucopolysacchariduria (HP:0008155) | 2.12224150 |
75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12224150 |
76 | Hypercortisolism (HP:0001578) | 2.11706649 |
77 | Hyporeflexia of lower limbs (HP:0002600) | 2.10553372 |
78 | Macroorchidism (HP:0000053) | 2.10387543 |
79 | Pointed chin (HP:0000307) | 2.10330269 |
80 | Insomnia (HP:0100785) | 2.10162764 |
81 | Agammaglobulinemia (HP:0004432) | 2.07613698 |
82 | Papilledema (HP:0001085) | 2.06389211 |
83 | Mitral regurgitation (HP:0001653) | 2.06277013 |
84 | Flat cornea (HP:0007720) | 2.06244003 |
85 | Polydipsia (HP:0001959) | 2.05120679 |
86 | Abnormal drinking behavior (HP:0030082) | 2.05120679 |
87 | Easy fatigability (HP:0003388) | 2.04776813 |
88 | Choreoathetosis (HP:0001266) | 2.04425321 |
89 | Xanthomatosis (HP:0000991) | 2.04078982 |
90 | Supranuclear gaze palsy (HP:0000605) | 2.03842039 |
91 | Hyperphosphaturia (HP:0003109) | 2.03292204 |
92 | Neoplasm of the heart (HP:0100544) | 2.03260377 |
93 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03075669 |
94 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03075669 |
95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03075669 |
96 | Abnormality of glycine metabolism (HP:0010895) | 2.02412340 |
97 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.02412340 |
98 | Gowers sign (HP:0003391) | 2.00954368 |
99 | Apathy (HP:0000741) | 2.00497107 |
100 | Protrusio acetabuli (HP:0003179) | 2.00340335 |
101 | Hyperammonemia (HP:0001987) | 2.00276476 |
102 | Bowel diverticulosis (HP:0005222) | 1.99506794 |
103 | Febrile seizures (HP:0002373) | 1.99414138 |
104 | Axonal loss (HP:0003447) | 1.98210940 |
105 | Cellulitis (HP:0100658) | 1.96852126 |
106 | Bulbar palsy (HP:0001283) | 1.96740887 |
107 | Peripheral hypomyelination (HP:0007182) | 1.96720663 |
108 | Abnormality of renin-angiotensin system (HP:0000847) | 1.96638554 |
109 | Generalized tonic-clonic seizures (HP:0002069) | 1.96045370 |
110 | Achilles tendon contracture (HP:0001771) | 1.95873849 |
111 | Myokymia (HP:0002411) | 1.95261108 |
112 | Spastic gait (HP:0002064) | 1.95147042 |
113 | Hypomagnesemia (HP:0002917) | 1.94133369 |
114 | Hypobetalipoproteinemia (HP:0003563) | 1.93077032 |
115 | Abnormal urine phosphate concentration (HP:0012599) | 1.92629363 |
116 | Foot dorsiflexor weakness (HP:0009027) | 1.91339483 |
117 | Turricephaly (HP:0000262) | 1.90447765 |
118 | Renal salt wasting (HP:0000127) | 1.89893103 |
119 | Back pain (HP:0003418) | 1.89492826 |
120 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88567662 |
121 | Growth hormone excess (HP:0000845) | 1.88527504 |
122 | Type II lissencephaly (HP:0007260) | 1.86986060 |
123 | Nonprogressive disorder (HP:0003680) | 1.86928123 |
124 | Asymmetric septal hypertrophy (HP:0001670) | 1.86902826 |
125 | Anteriorly placed anus (HP:0001545) | 1.86821070 |
126 | Pheochromocytoma (HP:0002666) | 1.86027591 |
127 | Hypokalemia (HP:0002900) | 1.85716698 |
128 | Hypercalcemia (HP:0003072) | 1.85412630 |
129 | Scanning speech (HP:0002168) | 1.84948856 |
130 | CNS hypomyelination (HP:0003429) | 1.84716485 |
131 | Abnormality of the corticospinal tract (HP:0002492) | 1.84322207 |
132 | Alacrima (HP:0000522) | 1.84137623 |
133 | Increased variability in muscle fiber diameter (HP:0003557) | 1.82955490 |
134 | Bundle branch block (HP:0011710) | 1.82426773 |
135 | Overriding aorta (HP:0002623) | 1.82197344 |
136 | Athetosis (HP:0002305) | 1.82101002 |
137 | Generalized aminoaciduria (HP:0002909) | 1.81854922 |
138 | Thoracic kyphosis (HP:0002942) | 1.81853935 |
139 | Irritability (HP:0000737) | 1.81154965 |
140 | Hyperacusis (HP:0010780) | 1.80687166 |
141 | Congenital glaucoma (HP:0001087) | 1.80520493 |
142 | Joint stiffness (HP:0001387) | 1.80449073 |
143 | Abnormality of renal excretion (HP:0011036) | 1.80212624 |
144 | Upper limb amyotrophy (HP:0009129) | 1.80151795 |
145 | Distal upper limb amyotrophy (HP:0007149) | 1.80151795 |
146 | Postural tremor (HP:0002174) | 1.79820676 |
147 | Truncus arteriosus (HP:0001660) | 1.78338064 |
148 | Nuclear cataract (HP:0100018) | 1.78261450 |
149 | Deformed sella turcica (HP:0002681) | 1.77828095 |
150 | Restlessness (HP:0000711) | 1.77778866 |
151 | Anxiety (HP:0000739) | 1.76891040 |
152 | Hypercalciuria (HP:0002150) | 1.76686095 |
153 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76177293 |
154 | Myopathic facies (HP:0002058) | 1.75853502 |
155 | Enlarged kidneys (HP:0000105) | 1.75515157 |
156 | Buphthalmos (HP:0000557) | 1.74507722 |
157 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73276759 |
158 | Thin ribs (HP:0000883) | 1.72884263 |
159 | Gonadal dysgenesis (HP:0000133) | 1.72838036 |
160 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72820081 |
161 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72413085 |
162 | Hyperparathyroidism (HP:0000843) | 1.72331082 |
163 | Distal arthrogryposis (HP:0005684) | 1.71592282 |
164 | Nemaline bodies (HP:0003798) | 1.71061094 |
165 | Elfin facies (HP:0004428) | 1.69979988 |
166 | Psychosis (HP:0000709) | 1.69885289 |
167 | Abnormality of the periventricular white matter (HP:0002518) | 1.69558478 |
168 | Retinal dysplasia (HP:0007973) | 1.69301634 |
169 | Abnormality of the foot musculature (HP:0001436) | 1.68901068 |
170 | Dysphonia (HP:0001618) | 1.68232450 |
171 | Depression (HP:0000716) | 1.67747621 |
172 | Hypsarrhythmia (HP:0002521) | 1.67688850 |
173 | Dysmetria (HP:0001310) | 1.67250268 |
174 | Testicular neoplasm (HP:0010788) | 1.66666365 |
175 | Progressive neurologic deterioration (HP:0002344) | 1.66514962 |
176 | Abnormality of magnesium homeostasis (HP:0004921) | 1.66039244 |
177 | EEG with generalized epileptiform discharges (HP:0011198) | 1.65170284 |
178 | Status epilepticus (HP:0002133) | 1.63390610 |
179 | Brushfield spots (HP:0001088) | 1.62886321 |
180 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.61357154 |
181 | Conjugated hyperbilirubinemia (HP:0002908) | 1.61106796 |
182 | Renal duplication (HP:0000075) | 1.59147946 |
183 | Hyperaldosteronism (HP:0000859) | 1.56465447 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 2.96128810 |
2 | NME2 | 2.92269361 |
3 | CDK19 | 2.91669756 |
4 | OXSR1 | 2.79582600 |
5 | WNK4 | 2.79266578 |
6 | BCKDK | 2.78222037 |
7 | FLT3 | 2.72280000 |
8 | ICK | 2.70042829 |
9 | STK39 | 2.67369221 |
10 | UHMK1 | 2.64126003 |
11 | MARK1 | 2.48302855 |
12 | MAPK15 | 2.40378520 |
13 | MAP3K11 | 2.29932215 |
14 | INSRR | 2.19000702 |
15 | DAPK2 | 2.10273993 |
16 | PASK | 2.07315370 |
17 | PRKD3 | 1.98936007 |
18 | PRPF4B | 1.85690402 |
19 | EEF2K | 1.84606098 |
20 | HIPK2 | 1.83620658 |
21 | NTRK2 | 1.79730292 |
22 | TRIB3 | 1.72881773 |
23 | NTRK1 | 1.64352016 |
24 | PKN2 | 1.58826132 |
25 | ARAF | 1.57280637 |
26 | EPHB1 | 1.53580399 |
27 | TESK1 | 1.50856721 |
28 | MAPKAPK5 | 1.48097317 |
29 | SIK1 | 1.46337241 |
30 | RIPK1 | 1.42403252 |
31 | MAP3K4 | 1.41028052 |
32 | PNCK | 1.38428410 |
33 | RPS6KA2 | 1.36981624 |
34 | MARK2 | 1.36172706 |
35 | PHKG2 | 1.35546484 |
36 | PHKG1 | 1.35546484 |
37 | DYRK1B | 1.35112847 |
38 | ERN1 | 1.33790125 |
39 | WNK1 | 1.33259080 |
40 | WNK3 | 1.32965905 |
41 | SMG1 | 1.32426131 |
42 | CSNK1G3 | 1.29568633 |
43 | EPHA4 | 1.29264712 |
44 | MAP2K4 | 1.25507003 |
45 | MAPK12 | 1.23842140 |
46 | PTK6 | 1.18007886 |
47 | FGFR2 | 1.17831630 |
48 | TGFBR1 | 1.12826677 |
49 | DYRK3 | 1.12496398 |
50 | CSNK1A1L | 1.11864471 |
51 | SCYL2 | 1.11173876 |
52 | MAP3K9 | 1.07187275 |
53 | CSF1R | 1.02837018 |
54 | PAK6 | 1.01348602 |
55 | CAMK1G | 0.99380486 |
56 | CSNK1G1 | 0.95360558 |
57 | RPS6KL1 | 0.92896706 |
58 | RPS6KC1 | 0.92896706 |
59 | CSNK1G2 | 0.92282392 |
60 | MAP3K7 | 0.91966268 |
61 | DMPK | 0.90963296 |
62 | MAP2K2 | 0.90339320 |
63 | CAMK1 | 0.88870163 |
64 | BTK | 0.88804035 |
65 | RET | 0.85879127 |
66 | LMTK2 | 0.85417012 |
67 | PIM2 | 0.85174767 |
68 | TLK1 | 0.84911507 |
69 | DDR2 | 0.84011910 |
70 | MAP3K1 | 0.82910649 |
71 | LATS2 | 0.82874626 |
72 | DAPK1 | 0.82867846 |
73 | TTN | 0.81305669 |
74 | MINK1 | 0.81296851 |
75 | PAK3 | 0.80253431 |
76 | PRKD2 | 0.80029338 |
77 | ADRBK2 | 0.79841067 |
78 | ABL2 | 0.79531541 |
79 | MAPK4 | 0.79393596 |
80 | VRK2 | 0.79187085 |
81 | MUSK | 0.78681097 |
82 | TYRO3 | 0.78192481 |
83 | TBK1 | 0.77914662 |
84 | BRAF | 0.77306085 |
85 | TNIK | 0.74629140 |
86 | PRKD1 | 0.72176141 |
87 | CDK14 | 0.71718823 |
88 | PTK2 | 0.71563316 |
89 | CAMKK2 | 0.70962362 |
90 | RPS6KA6 | 0.70347226 |
91 | CDK15 | 0.69767352 |
92 | CAMKK1 | 0.68878232 |
93 | SGK494 | 0.68108273 |
94 | SGK223 | 0.68108273 |
95 | CDK11A | 0.67908210 |
96 | PAK4 | 0.67796196 |
97 | ROCK2 | 0.67334792 |
98 | PIK3CG | 0.65333610 |
99 | NTRK3 | 0.64955771 |
100 | PRKCG | 0.64890522 |
101 | RPS6KB2 | 0.64632949 |
102 | IRAK3 | 0.63919287 |
103 | CDK5 | 0.63654486 |
104 | TAOK2 | 0.63294095 |
105 | CDK8 | 0.62631995 |
106 | TESK2 | 0.62596975 |
107 | CDK18 | 0.62082965 |
108 | ILK | 0.61820154 |
109 | MAPKAPK3 | 0.61374445 |
110 | FES | 0.60262672 |
111 | ALK | 0.59087552 |
112 | PDPK1 | 0.58704070 |
113 | STK11 | 0.58657606 |
114 | PAK2 | 0.57950668 |
115 | KIT | 0.57453098 |
116 | CAMK4 | 0.56962022 |
117 | MAP2K7 | 0.56818657 |
118 | TNK2 | 0.56196883 |
119 | MAPK7 | 0.56075699 |
120 | TGFBR2 | 0.55088550 |
121 | CAMK2B | 0.54319344 |
122 | PKN1 | 0.54268353 |
123 | OBSCN | 0.53043004 |
124 | MAP2K1 | 0.52663500 |
125 | LRRK2 | 0.52610098 |
126 | MAPK10 | 0.52549500 |
127 | SGK2 | 0.50946336 |
128 | PDGFRA | 0.49859540 |
129 | CLK1 | 0.49402634 |
130 | CAMK2G | 0.49214128 |
131 | DAPK3 | 0.49118764 |
132 | MAP4K1 | 0.49013280 |
133 | MET | 0.48957606 |
134 | GRK6 | 0.47814726 |
135 | SIK2 | 0.47123056 |
136 | PRKCH | 0.45919089 |
137 | MATK | 0.45090458 |
138 | MAPK13 | 0.41912733 |
139 | CAMK2D | 0.39483323 |
140 | PINK1 | 0.37930605 |
141 | LIMK1 | 0.37836318 |
142 | MTOR | 0.36394551 |
143 | NEK6 | 0.35114597 |
144 | PDK1 | 0.34935875 |
145 | DYRK1A | 0.34776463 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.50143635 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.71159317 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58507427 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23225172 |
5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19571279 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11122016 |
7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07865463 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01253663 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95877325 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84426174 |
11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.78996866 |
12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73479036 |
13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72114159 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68684382 |
15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63869835 |
16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63109789 |
17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62582241 |
18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.61740556 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61314602 |
20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60624450 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57959768 |
22 | Protein export_Homo sapiens_hsa03060 | 1.56091997 |
23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56054876 |
24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53903514 |
25 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.48415484 |
26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47252509 |
27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42172076 |
28 | Insulin secretion_Homo sapiens_hsa04911 | 1.41699979 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.41402436 |
30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41000944 |
31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37171430 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35883738 |
33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.35791487 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.30336106 |
35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28156124 |
36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27683448 |
37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24876554 |
38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20240860 |
39 | Peroxisome_Homo sapiens_hsa04146 | 1.18857112 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18497935 |
41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18089060 |
42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17168460 |
43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16890190 |
44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15906737 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14827804 |
46 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12495086 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10964004 |
48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10712408 |
49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07619945 |
50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04701729 |
51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03112021 |
52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.99984910 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99876690 |
54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99088121 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99003328 |
56 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98099524 |
57 | Renin secretion_Homo sapiens_hsa04924 | 0.96867041 |
58 | Glioma_Homo sapiens_hsa05214 | 0.96123309 |
59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96045573 |
60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94932766 |
61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94272527 |
62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93864344 |
63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93338544 |
64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92883411 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92173363 |
66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92150729 |
67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87286747 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86703260 |
69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85695196 |
70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84708899 |
71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82184966 |
72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81668825 |
73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80574015 |
74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79696924 |
75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78745530 |
76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77692622 |
77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77663755 |
78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75882432 |
79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74693096 |
80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74531450 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73611889 |
82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72943703 |
83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72676653 |
84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.72212792 |
85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71069816 |
86 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70205756 |
87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69587360 |
88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69556213 |
89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69056508 |
90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68832588 |
91 | Lysine degradation_Homo sapiens_hsa00310 | 0.68626820 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68555812 |
93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68343462 |
94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67991404 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65804858 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65401838 |
97 | Morphine addiction_Homo sapiens_hsa05032 | 0.65390207 |
98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64149354 |
99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64035417 |
100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63340153 |
101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63184815 |
102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62210987 |
103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62000153 |
104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61629127 |
105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60936271 |
106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59497696 |
107 | Salivary secretion_Homo sapiens_hsa04970 | 0.58811731 |
108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58736046 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.58203277 |
110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57990398 |
111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57671253 |
112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57657772 |
113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56259767 |
114 | Long-term depression_Homo sapiens_hsa04730 | 0.56210844 |
115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55884974 |
116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55719179 |
117 | Prion diseases_Homo sapiens_hsa05020 | 0.55691942 |
118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55592256 |
119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54317777 |
120 | Taste transduction_Homo sapiens_hsa04742 | 0.54161640 |
121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54093567 |
122 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53319866 |
123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53093494 |
124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52324950 |
125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52119129 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51486177 |
127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51373791 |
128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50483908 |
129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49412195 |
130 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48276458 |
131 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47152145 |
132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47097182 |
133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46801436 |
134 | Asthma_Homo sapiens_hsa05310 | 0.46563491 |
135 | Axon guidance_Homo sapiens_hsa04360 | 0.46375858 |
136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44702465 |
137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42685174 |
138 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42608696 |
139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42165723 |
140 | Alcoholism_Homo sapiens_hsa05034 | 0.41760480 |
141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41619627 |
142 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41117228 |
143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40635683 |
144 | ABC transporters_Homo sapiens_hsa02010 | 0.39245448 |
145 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39232705 |
146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38769707 |
147 | Melanogenesis_Homo sapiens_hsa04916 | 0.38528180 |
148 | Ribosome_Homo sapiens_hsa03010 | 0.38459763 |
149 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38393284 |
150 | Gap junction_Homo sapiens_hsa04540 | 0.37951920 |
151 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37184110 |
152 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37177845 |
153 | Bladder cancer_Homo sapiens_hsa05219 | 0.37091821 |